Apigenin, a dietary flavonoid, inhibits proliferation of human bladder cancer T-24 cells via blocking cell cycle progression and inducing apoptosis

Cancer Cell International

Volumn 15, Issue 1, 2015, Pages

  Shi, Ming Der ^a,b   Shiao, Cheng Kai ^a   Lee, Yi Chieh ^b   Shih, Yuan Wei ^b  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHUNG HWA UNIVERSITY OF MEDICAL TECHNOLOGY   (Taiwan)

Author keywords

Apigenin; Caspase; CDK; Cyclin; Mitochondrial membrane potential

Indexed keywords

APIGENIN; CASPASE 3; CASPASE 7; CASPASE 9; CYCLIN A; CYCLIN B1; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 2; CYCLIN E; GLUTATHIONE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN P21; PROTEIN P27; PROTEIN P53; PROTEIN TYROSINE PHOSPHATASE; SUPEROXIDE DISMUTASE;

APOPTOSIS; ARTICLE; BLADDER CANCER; CANCER CELL; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; PROTEIN EXPRESSION;

EID: 84926650035     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/s12935-015-0186-0     Document Type: Article

References (43)

1. Allareddy V, Kennedy J, West MM, Konety BR. Quality of life in long-term survivors of bladder cancer. Cancer. 2006;106:2355-62.
2. Cookson MS, Herr HW, Zhang ZF, Soloway S, Sogani PC, Fair WR. The treated natural history of high risk superficial bladder cancer: 15-year outcome. J Urol. 1997;58:62-7.
3. Herr HW. Natural history of superficial bladder tumors: 10- to 20-year follow-up of treated patients. World J Urol. 1997;15:84-8.
4. Sudarshan S, Holman DH, Hyer ML, Voelkel-Johnson C, Dong JY, Norris JS. In vitro efficacy of Fas ligand gene therapy for the treatment of bladder cancer. Cancer Gene Ther. 2005;12:12-8.
5. Dinney CP, McConkey DJ, Millikan RE, Wu X, Bar-Eli M, Adam L, et al. Focus on bladder cancer. Cancer Cell. 2004;6:111-6.
6. McConkey DJ, Lee S, Choi W, Tran M, Majewski T, Lee S, et al. Molecular genetics of bladder cancer: emerging mechanisms of tumor initiation and progression. Urol Oncol. 2010;28:429-40.
7. Goebell PJ, Knowles MA. Bladder cancer or bladder cancers? genetically distinct malignant conditions of the urothelium. Urol Oncol. 2010;28:409-28.
8. Netto GJ. Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet? Nat Rev Urol. 2011;9:41-51.
9. Hengartner MO. The biochemistry of apoptosis. Nature. 2000;407:770-6.
10. Hail Jr N, Carter BZ, Konopleva M, Andreeff M. Apoptosis effector mechanisms: a requiem performed in different keys. Apoptosis. 2006;11:889-904.
11. Hartmann A, Troadec JD, Hunot S, Kikly K, Faucheux BA, Mouatt-Prigent A, et al. Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson's disease, but pathway inhibition results in neuronal necrosis. J Neurosci. 2001;21:2247-55.
12. Kalai M, Van Loo G, Vanden Berghe T, Meeus A, Burm W, Saelens X, et al. Tipping the balance between necrosis and apoptosis in human and murine cells treated with interferon and dsRNA. Cell Death Differ. 2002;9:981-94.
13. Nicotera P. Molecular switches deciding the death of injured neurons. Toxicol Sci. 2003;74:4-9.
14. Gosslau A, Chen KY. Nutraceuticals, apoptosis, and disease prevention. Nutrition. 2004;20:95-102.
15. Poot M, Teubert H, Rabinovitch PS, Kavanagh TJ. De novo synthesis of glutathione is required for both entry into and progression through the cell cycle. J Cell Physiol. 1995;163:555-60.
16. Schnelldorfer T, Gansauge S, Gansauge F, Schlosser S, Beger HG, Nussler AK. Glutathione depletion causes cell growth inhibition and enhanced apoptosis in pancreatic cancer cells. Cancer. 2000;89:1440-7.
17. MacLachian TK, Sang N, Giordano A. Cyclins, Cyclin-dependent kinases and Cdk inhibitors: implications in cell cycle control and cancer. Crit Rev Eukaryot Gene Expr. 1995;5:127-56.
18. Spataro V. Recent advances in the molecular genetics of cancer. Ann Oncol. 1998;9:23-9.
19. Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem. 2004;73:39-85.
20. Donaldson MS. Nutrition and cancer: a review of the evidence for an anti-cancer diet. Nutr J. 2004;3:19.
21. Duthie G, Crozier A. Plant-derived phenolic antioxidants. Curr Opin Clin Nutr Metab Ccare. 2000;3:447-51.
22. Wang W, Heideman L, Chung CS, Pelling JC, Koehler KJ, Birt DF. Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines. Mol Carcinog. 2000;28:102-10.
23. Zheng PW, Chiang LC, Lin CC. Apigenin induced apoptosis through p53-dependent pathway in human cervical carcinoma cells. Life Sci. 2005;76:1367-79.
24. Czyz J, Madeja Z, Irmer U, Korohoda W, Hülser DF. Flavonoid apigenin inhibits motility and invasiveness of carcinoma cells in vitro. Int J Cancer. 2005;114:12-8.
25. Fang J, Zhou Q, Liu LZ, Xia C, Hu X, Shi X, et al. Apigenin inhibits tumor angiogenesis through decreasing HIF-1alpha and VEGF expression. Carcinogenesis. 2007;28:858-64.
26. LeBel CP, Ischiopoulos H, Bondy SC. Evaluation of the probe 2,7-dichloro- fluorescin as indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol. 1992;5:227-31.
27. Hisin PJ, Hilf R. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem. 1976;74:214-26.
28. Patel T. Apoptosis in hepatic pathophysiology. Clin Liver Dis. 2000;4:295-317.
29. Chandra J, Samali A, Orrenius S. Triggering and modulation of apoptosis by oxidative stress. Free Radic Biol Med. 2000;29:323-33.
30. Havsteen B. Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol. 1983;32:1141-8.
31. Li RW, Theriault AG, Au K, Douglas TD, Casaschi A, Kurowska EM, et al. Citrus polymethoxylated flavones improve lipid and glucose homeostasis and modulate adipokines in fructose-induced insulin resistant hamsters. Life Sci. 2006;79:365-73.
32. Kuhnau J. The flavonoids. A class of semi-essential food components: their role in human nutrition. World Rev Nutr Diet. 1976;24:117-91.
33. Hollman PC, de Vries JH, van Leeuwen SD, Mengelers MJ, Katan MB. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am J Clin Nutr. 1995;62:1276-82.
34. Hollman PC, van Trijp JM, Buysman MN, van der Gaag MS, Mengelers MJ, de Vries JH, et al. Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man. FEBS Lett. 1997;418:152-6.
35. Das S, Das J, Samadder A, Paul A, Khuda-Bukhsh AR. Efficacy of PLGA-loaded apigenin nanoparticles in Benzo[a]pyrene and ultraviolet-B induced skin cancer of mice: Mitochondria mediated apoptotic signalling cascades. Food Chem Toxicol. 2013;62:670-80.
36. Kuo PL, Hsu YL. The grape and wine constituent piceatannol inhibits proliferation of human bladder cancer cells via blocking cell cycle progression and inducing Fas/ membrane bound Fas ligand-mediated apoptotic pathway. Mol Nutr Food Res. 2008;52:408-18.
37. May P, May E. Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene. 1999;18:7621-36.
38. Vidal A, Koff A. Cell-cycle inhibitors: Three families united by a common cause. Gene. 2000;247:1-15.
39. Chan KC, Ho HH, Peng CH, Lan KP, Lin MC. Polyphenol-rich extract from mulberry leaf inhibits vascular smooth muscle cell proliferation involving upregulation of p53 and inhibition of cyclin-dependent kinase. J Agric Food Chem. 2010;58:2536-42.
40. Zoratti M, Szabo I. The mitochondrial permeability transi-tion. Biochim Biophys Acta. 1995;1241:139-76.
41. Hsu YL, Yu HS, Lin HC, Wu KY, Yang RC, Kuo PL. Heat shock induces apoptosis through reactive oxygen species involving mitochondrial and death receptor pathways in corneal cells. Exp Eye Res. 2011;93:405-12.
42. Lotem J, Sachs L. Regulation by bcl-2, c-myc, and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation- competent and-defective myeloid leukemic cells. Cell Growth Differ. 1993;4:41-7.
43. Isabelle M, Moreel X, Gagné JP, Rouleau M, Ethier C, Gagné P, et al. Investigation of PARP-1, PARP-2, and PARG interactomes by affinity-purification mass spectrometry. Proc Natl Acad Sci U S A. 2010;8:22.